Meta-substituted Biphenyl Peripherally Restricted Faah Inhibitors

Abstract

The present invention provides methods of making and using peripherally restricted inhibitors of fatty acid amide hydrolase (FAAH). The present invention provides compounds and compositions that suppress FAAH activity and increases anandamide levels outside the central nervous system (CNS). The present invention also sets forth methods for inhibiting FAAH as well as methods for treating conditions such as, but not limited to, pain, inflammation, immune disorders, dermatitis, mucositis, the over reactivity of peripheral sensory neurons, neurodermatitis, and an overactive bladder. Accordingly, the invention also provides compounds, methods, and pharmaceutical compositions for treating conditions in which the selective inhibition of peripheral FAAH (as opposed to CNS FAAH) would be of benefit.


Claims
Download PDF
Document Preview
Document History
  • Publication: Feb 28, 2013
  • Application: Aug 17, 2012
    WO US 2012/0051478 W
  • Priority: Aug 19, 2011
    US US 201161525636 P

Download Citation


Sign in to the Lens

Feedback